A year ago, Eli Lilly & Co. was poised to become the first pharmaceutical company to register a trillion-dollar market ...

Eli Lilly's growth is fueled by GLP-1 blockbusters and a solid pipeline, yet high valuations and reliance on key drugs ...

Eli Lilly and Company opens new technology and innovation site in Hyderabad, India to enhance global operations.

Lilly expands India presence with inauguration of Hyderabad site to accelerate global digital innovation: Our Bureau, Mumbai ...

Telangana Chief Minister A. Revanth Reddy inaugurated US pharma major Eli Lilly’s Global Capability Centre (GCC) in Hyderabad ...

The US pharmaceutical giant has already hired 100 professionals and plans to expand its headcount to 1,500 in the coming ...

A Lilly study showed Mounjaro resulted in a lower risk of heart attacks and strokes in patients with diabetes compared with ...

Lilly has already taken 100 professionals at the Hyderabad facility and plans to expand the headcount to 1,500 over the next ...

Eli Lilly said it believes the new data bolsters the case for Mounjaro to be prescribers’ first choice for patients with Type ...

Eli Lilly and Company (NYSE:LLY) is one of the Stocks With Huge Catalysts on the Horizon. On July 21, Eli Lilly and Company ...

Eli Lilly and Company has opened a technology and innovation center in, India. This strategic hub, covering 2.2 lakh sqft, ...

Eli Lilly said on Thursday that its newer diabetes drug Mounjaro outperformed Trulicity, its previously top-selling ...